Company / Net Debt per Share
PROCEPT BioRobotics Corp Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$4.29
FY2025
5-year range
-$53.96 / -$4.06
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
#89 of 98
Health Care
What the data says
Among 98 Health Care companies, PROCEPT BioRobotics Corp is in the top 9% for net debt per share. Net Debt per Share has fluctuated over the past 6 years, ranging from $-53.96 in FY2021 to $-4.06 in FY2023.
Based on SEC 10-K filings.
-4.29 in FY2025.
Improved from $-4.06 to $-4.29 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 98This company -$4.29 Sector average $7.39
▼
-158.1% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 22.8% year-over-year.
- Ranks #89 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2023.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.29 | +22.8% |
| FY2024 | -$5.56 | -37.1% |
| FY2023 | -$4.06 | +73.6% |
| FY2022 | -$15.36 | +71.5% |
| FY2021 | -$53.96 | -254.7% |
| FY2020 | -$15.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026